Method of preventing blood coagulation and drug-eluting implant for percutaneous coronary intervention

Abstract

The present disclosure provides a method of preventing blood coagulation, comprising administering an effective amount of a ginsenoside Compound K (CK) to a subject in need. The present disclosure also provides use of a ginsenoside Compound K (CK) in the manufacture a medicament for preventing blood coagulation. Further, the present disclosure provides a drug-eluting percutaneous coronary intervention (PCI), comprising a blood vessel implant, wherein a surface of the blood vessel implant is coated with a first layer comprising ginsenoside Compound K (CK) and a first bioabsorbable polymer, wherein the first bioabsorbable polymer comprises Poly-L-lactic acid (PLLA) and Poly (L-Lactide-co-ε-Caprolactone) (PLCL) in a weight ratio of 60%-80%:20%-40%.

Dependencies are inferred from the claim text.